Pathologic burden goes with the flow: MRI perfusion and pathologic burden in frontotemporal lobar degeneration due to

Christopher A Olm1,2, Claire S Peterson3, David J Irwin3

  • 1Penn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Regional cerebral blood flow (CBF) measured by arterial spin labeling (ASL) MRI is linked to tau pathology in frontotemporal lobar degeneration (FTLD-tau). Reduced CBF and gray matter volume together better predict tau burden than either alone.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Neurodegenerative Diseases

Background:

  • Regional cerebral blood flow (CBF) changes quantified using arterial spin labeling (ASL) are altered in frontotemporal lobar degeneration with tau pathology (FTLD-FTLD-tau).
  • The direct relationship between ASL-derived CBF and the extent of FTLD-tau pathology has not been previously assessed.

Purpose of the Study:

  • To determine if antemortem regional ASL CBF in patients with FTLD-tau correlates with postmortem pathologic burden in the same brain regions.
  • To directly test the imaging-pathology relationship in FTLD-tau.

Main Methods:

  • A case-control study involving 21 autopsy-confirmed FTLD-tau patients and 25 controls.
  • Antemortem ASL and T1-weighted MRI were acquired to estimate regional CBF and gray matter (GM) volumes.
  • Postmortem digital quantification assessed the percent area occupied by FTLD-tau pathology.

Main Results:

  • FTLD-tau patients showed hypoperfusion in anterior cingulate, orbitofrontal, middle frontal, superior temporal, and angular gyrus regions compared to controls.
  • Regional CBF in FTLD-tau patients was significantly associated with pathologic burden (p < 0.005).
  • Models combining GM volume and CBF provided a better fit to pathologic burden data than single-modality models (p < 0.05).

Conclusions:

  • Reduced ASL CBF is associated with increased FTLD-tau pathologic burden.
  • ASL-derived CBF offers complementary predictive value to structural MRI for assessing FTLD-tau pathology.